Tg Therapeutics (TGTX) Other Working Capital Changes (2012 - 2026)

Tg Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$424000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 21.92% year-over-year to -$424000.0 in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 15.2% increase from a year earlier, with the FY2025 full-year figure at -$2.1 million, up 12.1% from the prior year.
• Other Working Capital Changes improved to -$424000.0 in Q1 2026 per TGTX's latest filing, from -$519000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $38.6 million in Q3 2025 and bottomed at -$10.7 million in Q1 2026.
• The 5-year median for Other Working Capital Changes is -$38000.0 (2022), against an average of $2.6 million.
• Across the five-year window, Other Working Capital Changes declined 0.68% in 2023 and advanced 21.92% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$591000.0 in 2022, then decreased by 0.68% to -$595000.0 in 2023, then dropped by 0.5% to -$598000.0 in 2024, then rose by 13.21% to -$519000.0 in 2025, then advanced by 18.3% to -$424000.0 in 2026.
• Per Business Quant, the three latest TGTX Other Working Capital Changes figures stand at -$424000.0 (Q1 2026), -$519000.0 (Q4 2025), and -$519000.0 (Q3 2025).